{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:32:31Z","timestamp":1759991551494,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MMR vaccine is a common vaccine that contains oncolytic viruses (Measles, Mumps, and Rubella) and could be used as a potential anti-cancer treatment. In this study, we assessed the anti-tumor activity of the MMR vaccine against Ehrlich ascites carcinoma (EAC) solid tumor induced in mice. The in vitro assay showed that vaccine IC50 in EAC was approximately 200 CCID<jats:sub>50.<\/jats:sub> The vaccine was intratumorally administrated twice\u00a0weekly in EAC-bearing mice. The antitumor response of the vaccine was measured by tumor growth, survival rate, histopathologic examination, flow cytometry analysis, and body biochemical parameters. The MMR vaccine demonstrated a substantial reduction of tumor growth and prolongation of life span as well. The proliferation marker was significantly lower in the vaccine-treated group. Moreover, the apoptosis key parameter Casp-3 was also higher in the vaccine-treated group. The vaccine somewhat restored the deterioration of the biochemical parameters (LDH, GOT, GPT, MDA, NO, and PON-1) in the tumor-bearing mice. Finally, this study indicated the potential antitumor effect of MMR vaccine via anti\u2011proliferative, apoptotic activities, and modulating the antioxidant parameters. This study opens a new field of inquiry for future research on the vaccine\u2019s anti-cancer properties.<\/jats:p>","DOI":"10.1007\/s12032-022-01866-x","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T07:04:37Z","timestamp":1667027077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of MMR live attenuated vaccine oncolytic potential using Ehrlich ascites carcinoma in a murine model"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-0091","authenticated-orcid":false,"given":"Sara T.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aly F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-2649","authenticated-orcid":false,"given":"Nourhan H.","family":"AbdelAllah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-0584","authenticated-orcid":false,"given":"Hamdallah","family":"Zedan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"1866_CR1","unstructured":"World Health Organization, W.H.O cancer. https:\/\/www.who.int\/health-topics\/cancer#tab=tab_1."},{"key":"1866_CR2","unstructured":"National Institutes of Health (NIH), N.C.I. types of cancer treatment. https:\/\/www.cancer.gov\/about-cancer\/treatment\/types."},{"key":"1866_CR3","unstructured":"American Cancer Society, A.C. cancer treatments types. https:\/\/www.cancer.org\/treatment\/treatments-and-side-effects\/treatment-types.html."},{"issue":"4","key":"1866_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/bjc.2015.481","volume":"114","author":"LW Seymour","year":"2016","unstructured":"Seymour LW, Fisher KD. Oncolytic viruses: finally delivering. Br J Cancer. 2016;114(4):357\u201361.","journal-title":"Br J Cancer"},{"issue":"4","key":"1866_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/2326-6066.CIR-14-0015","volume":"2","author":"EA Chiocca","year":"2014","unstructured":"Chiocca EA, Rabkin SD. Oncolytic viruses and their application to cancer immunotherapy. Cancer Immunol Res. 2014;2(4):295\u2013300.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"1866_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1596006","volume":"8","author":"ME Davola","year":"2019","unstructured":"Davola ME, Mossman KL. Oncolytic viruses: how \u201clytic\u201d must they be for therapeutic efficacy? Oncoimmunology. 2019;8(6): e1581528.","journal-title":"Oncoimmunology"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fonc.2017.00195","volume":"7","author":"A Howells","year":"2017","unstructured":"Howells A, et al. Oncolytic viruses\u2014interaction of virus and tumor cells in the battle to eliminate cancer. Front Oncol. 2017;7:195.","journal-title":"Front Oncol"},{"key":"1866_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fonc.2017.00202","volume":"7","author":"SR Jhawar","year":"2017","unstructured":"Jhawar SR, et al. Oncolytic viruses\u2014natural and genetically engineered cancer immunotherapies. Front Oncol. 2017;7:202.","journal-title":"Front Oncol"},{"issue":"6","key":"1866_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jamaoncol.2016.2064","volume":"3","author":"SE Lawler","year":"2017","unstructured":"Lawler SE, et al. Oncolytic viruses in cancer treatment. JAMA Oncol. 2017;3(6):841.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1866_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","volume":"254","author":"MJV V\u00e4h\u00e4-Koskela","year":"2007","unstructured":"V\u00e4h\u00e4-Koskela MJV, Heikkil\u00e4 JE, Hinkkanen AE. Oncolytic viruses in cancer therapy. Cancer Lett. 2007;254(2):178\u2013216.","journal-title":"Cancer Lett"},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.omto.2019.10.007","volume":"15","author":"M Zheng","year":"2019","unstructured":"Zheng M, et al. Oncolytic viruses for cancer therapy: barriers and recent advances. Mol Ther-Oncol. 2019;15:234\u201347.","journal-title":"Mol Ther-Oncol"},{"issue":"13","key":"1866_CR12","first-page":"2375","volume":"10","author":"M Ozaslan","year":"2011","unstructured":"Ozaslan M, et al. Ehrlich ascites carcinoma. Afr J Biotechnol. 2011;10(13):2375\u20138.","journal-title":"Afr J Biotechnol"},{"issue":"1","key":"1866_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-23669-9","volume":"8","author":"S Mishra","year":"2018","unstructured":"Mishra S, et al. Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy. Sci Rep. 2018;8(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"2","key":"1866_CR14","first-page":"81","volume":"5","author":"A Muralidhar","year":"2014","unstructured":"Muralidhar A, et al. Anticancer activity of Tephrosia purpurea root extracts against Ehrlich Ascites Carcinoma (EAC) cells in Swiss albino mice. Der Pharmacia Sinica. 2014;5(2):81\u20137.","journal-title":"Der Pharmacia Sinica"},{"key":"1866_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5162687","author":"MA Aldubayan","year":"2019","unstructured":"Aldubayan MA, et al. Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/5162687.","journal-title":"Oxid Med Cell Longev"},{"key":"1866_CR16","doi-asserted-by":"publisher","first-page":"108908","DOI":"10.1016\/j.biopha.2019.108908","volume":"115","author":"MA Abd Eldaim","year":"2019","unstructured":"Abd Eldaim MA, et al. Grape seeds proanthocyanidin extract ameliorates Ehrlich solid tumor induced renal tissue and DNA damage in mice. Biomed Pharmacother. 2019;115:108908.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1866_CR17","first-page":"227","volume":"43","author":"BN La Du","year":"1988","unstructured":"La Du BN. The human serum paraoxonase\/arylesterase polymorphism. Am J Hum Genet. 1988;43(3):227.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1866_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70\u20137.","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"1866_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1096\/fasebj.7.2.8440411","volume":"7","author":"S Archer","year":"1993","unstructured":"Archer S. Measurement of nitric oxide in biological models. FASEB J. 1993;7(2):349\u201360.","journal-title":"FASEB J"},{"issue":"10","key":"1866_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/BF02534475","volume":"19","author":"V Nair","year":"1984","unstructured":"Nair V, Turner GA. The thiobarbituric acid test for lipid peroxidation: structure of the adduct with malondialdehyde. Lipids. 1984;19(10):804\u20135.","journal-title":"Lipids"},{"issue":"12","key":"1866_CR21","first-page":"114","volume":"10","author":"B Elmund","year":"2020","unstructured":"Elmund B, Hartrianti P. Evaluation of mangosteen (Garcinia mangostana) antioxidant activity in clinical trials and in vivo animal studies: a systematic review. J Appl Pharm Sci. 2020;10(12):114\u201329.","journal-title":"J Appl Pharm Sci"},{"key":"1866_CR22","volume-title":"Theory and practice of histological techniques","author":"J Bancroft","year":"1996","unstructured":"Bancroft J, Stevens A, Turner D. Theory and practice of histological techniques. 4th ed. New York: Churchill Living Stone; 1996.","edition":"4"},{"issue":"4","key":"1866_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/path.1711680404","volume":"168","author":"G Cattoretti","year":"1992","unstructured":"Cattoretti G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168(4):357\u201363.","journal-title":"J Pathol"},{"key":"1866_CR24","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3389\/fonc.2020.01786","volume":"10","author":"G-D Cao","year":"2020","unstructured":"Cao G-D, et al. The oncolytic virus in cancer diagnosis and treatment. Front Oncol. 2020;10:1786.","journal-title":"Front Oncol"},{"issue":"1","key":"1866_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-020-00922-1","volume":"13","author":"O Hemminki","year":"2020","unstructured":"Hemminki O, dos Santos JM, Hemminki A. Oncolytic viruses for cancer immunotherapy. J Hematol Oncol. 2020;13(1):84.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1866_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jamaoncol.2016.2064","volume":"3","author":"SE Lawler","year":"2017","unstructured":"Lawler SE, et al. Oncolytic viruses in cancer treatment: a review. JAMA Oncol. 2017;3(6):841\u20139.","journal-title":"JAMA Oncol"},{"issue":"7","key":"1866_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1933719110395401","volume":"18","author":"E Tousson","year":"2011","unstructured":"Tousson E, et al. Proliferating cell nuclear antigen as a molecular biomarker for spermatogenesis in PTU-induced hypothyroidism of rats. Reprod Sci. 2011;18(7):679\u201386.","journal-title":"Reprod Sci"},{"issue":"1","key":"1866_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40064-016-2269-3","volume":"5","author":"ML Salem","year":"2016","unstructured":"Salem ML, et al. In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model. Springerplus. 2016;5(1):1\u201312.","journal-title":"Springerplus"},{"key":"1866_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nut.2018.06.018","volume":"58","author":"NKB El-Din","year":"2019","unstructured":"El-Din NKB, Ali DA, Abou-El-Magd RF. Grape seeds and skin induce tumor growth inhibition via G1-phase arrest and apoptosis in mice inoculated with Ehrlich ascites carcinoma. Nutrition. 2019;58:100\u20139.","journal-title":"Nutrition"},{"issue":"10","key":"1866_CR30","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1074\/jbc.M008363200","volume":"276","author":"EA Slee","year":"2001","unstructured":"Slee EA, Adrain C, Martin SJ. Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem. 2001;276(10):7320\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"1866_CR31","first-page":"175","volume":"6","author":"S Ibrahim","year":"2013","unstructured":"Ibrahim S, El-Kabany H. Effect of Ganoderma lucidum (g. lucidum) on the liver of mice bearing ehrlich solid tumor (EST) and exposed to \u03b3-radiation. J Radiat Res Appl Sci. 2013;6(1):175\u201396.","journal-title":"J Radiat Res Appl Sci"},{"key":"1866_CR32","first-page":"137","volume":"47","author":"G Konjevi\u0107","year":"2002","unstructured":"Konjevi\u0107 G, et al. Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors. Glas. Srpska Akademija Nauka i umetnosti. Odeljenje Medicinskih Nauka. 2002;47:137\u201347.","journal-title":"Odeljenje Medicinskih Nauka"},{"issue":"1","key":"1866_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5530\/ijper.50.1.16","volume":"50","author":"SP Gawade","year":"2016","unstructured":"Gawade SP, Tamboli MA, Thorat SS. Anti-tumor activity of viper snake venom photo-products SV1 and SV2 against ehrlich ascites carcinoma in mice. Indian J Pharm Educ Res. 2016;50(1):123\u20139.","journal-title":"Indian J Pharm Educ Res"},{"issue":"9","key":"1866_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3109\/13880209.2011.557080","volume":"49","author":"S Bhattacharya","year":"2011","unstructured":"Bhattacharya S, et al. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice. Pharm Biol. 2011;49(9):927\u201335.","journal-title":"Pharm Biol"},{"issue":"8","key":"1866_CR35","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/ars.2018.7527","volume":"30","author":"V Somasundaram","year":"2019","unstructured":"Somasundaram V, et al. Molecular mechanisms of nitric oxide in cancer progression, signal transduction, and metabolism. Antioxid Redox Signal. 2019;30(8):1124\u201343.","journal-title":"Antioxid Redox Signal"},{"key":"1866_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.biocel.2016.06.008","volume":"81","author":"M Castellazzi","year":"2016","unstructured":"Castellazzi M, et al. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases. Int J Biochem Cell Biol. 2016;81:356\u201363.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"1866_CR37","first-page":"2","volume":"65","author":"O Abdel-Salam","year":"2022","unstructured":"Abdel-Salam O, et al. Inhibition Of pentylenetetrazole-induced seizures and neuronal injury by brilliant blue G: role Of oxidative stress, and brain derived neurotrophic factor. Egypt J Chem. 2022;65(8):2\u20136.","journal-title":"Egypt J Chem"},{"key":"1866_CR38","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/mto.2015.11","volume":"2","author":"OV Matveeva","year":"2015","unstructured":"Matveeva OV, et al. Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency. Mol Ther-Oncol. 2015;2:15011.","journal-title":"Mol Ther-Oncol"},{"issue":"5","key":"1866_CR39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/clpt.2010.211","volume":"88","author":"E Galanis","year":"2010","unstructured":"Galanis E. Therapeutic potential of oncolytic measles virus: promises and challenges. Clin Pharmacol Ther. 2010;88(5):620\u20135.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1866_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1134\/S0026893318040027","volume":"52","author":"Y Ammour","year":"2018","unstructured":"Ammour Y, et al. Oncolytic properties of a mumps virus vaccine strain in human melanoma cell lines. Mol Biol. 2018;52(4):570\u20136.","journal-title":"Mol Biol"},{"issue":"4","key":"1866_CR41","first-page":"571","volume":"136","author":"PK Singh","year":"2012","unstructured":"Singh PK, et al. Oncolytic viruses & their specific targeting to tumour cells. Indian J Med Res. 2012;136(4):571\u201384.","journal-title":"Indian J Med Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01866-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01866-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T03:30:54Z","timestamp":1673839854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01866-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01866-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"14 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed following the guidelines for the care and use of laboratory animals approved by the Research Ethics Committee (Faculty of Pharmacy, Cairo University, Egypt), Approval No. MI (2627).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6"}}